197 related articles for article (PubMed ID: 29359509)
1. Survivin is a negative prognostic factor in malignant pleural effusion.
Arellano-Orden E; Romero-Romero B; Sánchez-López V; Martín-Juan J; Rodríguez-Panadero F; Otero-Candelera R
Eur J Clin Invest; 2018 Apr; 48(4):. PubMed ID: 29359509
[TBL] [Abstract][Full Text] [Related]
2. Survival in patients with malignant pleural effusion undergoing talc pleurodesis.
Hassan M; Mercer RM; Maskell NA; Asciak R; McCracken DJ; Bedawi EO; Shaarawy H; El-Ganady A; Psallidas I; Miller RF; Rahman NM
Lung Cancer; 2019 Nov; 137():14-18. PubMed ID: 31521977
[TBL] [Abstract][Full Text] [Related]
3. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
Thomas R; Fysh ETH; Smith NA; Lee P; Kwan BCH; Yap E; Horwood FC; Piccolo F; Lam DCL; Garske LA; Shrestha R; Kosky C; Read CA; Murray K; Lee YCG
JAMA; 2017 Nov; 318(19):1903-1912. PubMed ID: 29164255
[TBL] [Abstract][Full Text] [Related]
4. Success rate of medical thoracoscopy and talc pleurodesis in malignant pleurisy: A single-centre experience.
Leemans J; Dooms C; Ninane V; Yserbyt J
Respirology; 2018 Jun; 23(6):613-617. PubMed ID: 29320805
[TBL] [Abstract][Full Text] [Related]
5. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
[TBL] [Abstract][Full Text] [Related]
6. [Value of thoracoscopy and talc pleurodesis in diagnosis and palliative treatment of malignant pleural mesothelioma].
Charvat JC; Brutsche M; Frey JG; Tschopp JM
Praxis (Bern 1994); 1998 Mar; 87(10):336-40. PubMed ID: 9545840
[TBL] [Abstract][Full Text] [Related]
7. Talc pleurodesis improves survival of patients with malignant pleural effusions: case-control study.
Korsic M; Badovinac S; Cucevic B; Janevski Z
Wien Klin Wochenschr; 2015 Dec; 127(23-24):963-9. PubMed ID: 25860847
[TBL] [Abstract][Full Text] [Related]
8. [Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].
Zhang W; Wang GF; Zhang H; Mu XD; Jin Z
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):600-2. PubMed ID: 19088831
[TBL] [Abstract][Full Text] [Related]
9. Thoracoscopic talc pleurodesis for malignant pleural effusion.
Love D; White D; Kiroff G
ANZ J Surg; 2003; 73(1-2):19-22. PubMed ID: 12534732
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions.
Diacon AH; Wyser C; Bolliger CT; Tamm M; Pless M; Perruchoud AP; Solèr M
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1445-9. PubMed ID: 11029359
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of pleural fluid pH in malignant epithelial mesothelioma after talc poudrage.
Aelony Y; Yao JF; King RR
Respiration; 2006; 73(3):334-9. PubMed ID: 16679752
[TBL] [Abstract][Full Text] [Related]
12. Failure of talc pleurodesis is associated with increased pleural fibrinolysis.
Rodriguez-Panadero F; Segado A; Martin Juan J; Ayerbe R; Torres Garcia I; Castillo J
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):785-90. PubMed ID: 7881671
[TBL] [Abstract][Full Text] [Related]
13. Tumor type influences the effectiveness of pleurodesis in malignant effusions.
Bielsa S; Hernández P; Rodriguez-Panadero F; Taberner T; Salud A; Porcel JM
Lung; 2011 Apr; 189(2):151-5. PubMed ID: 21331598
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
Kolschmann S; Ballin A; Gillissen A
Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of systemic and local inflammation parameters in talc pleurodesis assessment.
Habal P; Omran N; Jankovicova K; Krejsek J; Mandak J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):234-41. PubMed ID: 25059234
[TBL] [Abstract][Full Text] [Related]
16. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma.
Crnjac A; Sok M; Kamenik M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):432-6. PubMed ID: 15296910
[TBL] [Abstract][Full Text] [Related]
17. Predictors of mortality within three months in the patients with malignant pleural effusion.
Ozyurtkan MO; Balci AE; Cakmak M
Eur J Intern Med; 2010 Feb; 21(1):30-4. PubMed ID: 20122610
[TBL] [Abstract][Full Text] [Related]
18. [Thoracoscopic pleurodesis in malignant pleural effusions].
Mitrofan C; Aldea A; Grigorescu C; Jitaru I; Iosep G; Aramă A; Danciu CE; Bolog S; Mihăescu T
Rev Med Chir Soc Med Nat Iasi; 2005; 109(4):799-803. PubMed ID: 16612848
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of medical thoracoscopy and thoracoscopic talc poudrage in patients with exudative pleural effusion.
Verma A; Taha A; Venkateswaran S; Tee A
Singapore Med J; 2015 May; 56(5):268-73. PubMed ID: 26034319
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of malignant pleural effusion by pleurodesis with talc].
Filippetti M; Crucitti G; Vanni B; Della Giulia M; Foggi P; Del Monte G
Chir Ital; 2000; 52(5):541-7. PubMed ID: 11190547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
